Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients

AIDS

Volumn 23, Issue 12, 2009, Pages 1511-1518

  Mallet, Vincent O ^a,b   Varthaman, Aditi ^c,d,e   Lasne, Dominique ^f   Viard, Jean Paul ^f   Gouya, Hervé ^b   Borgel, Delphine ^g,h   Lacroix Desmazes, Sébastien ^c,d,e   Pol, Stanislas ^a,b  

^a INSTITUT COCHIN   (France)

^b Unité d'Hépatologie ^*  (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g HÔPITAL AMBROISE PARÉ   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Autoimmunity; HIV infections complications; Hypertension portal etiology; Protein S deficiency

Indexed keywords

ANTIRETROVIRUS AGENT; COMPLEMENT COMPONENT C4B BINDING PROTEIN; DIDANOSINE; IMMUNOGLOBULIN G; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NODULAR HYPERPLASIA; PORTAL PHLEBOGRAPHY; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN S DEFICIENCY; VEIN DISEASE;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COMPLEMENT C4B-BINDING PROTEIN; FEMALE; HIV INFECTIONS; HUMANS; HYPERPLASIA; HYPERTENSION, PORTAL; IMMUNOGLOBULIN G; LIVER; MALE; MIDDLE AGED; PORTAL VEIN; PORTOGRAPHY; PROTEIN S; PROTEIN S DEFICIENCY;

EID: 68649114845     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832bfa51     Document Type: Article

References (28)

1. Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, et al. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat 2007; 14:183-188.
2. Weber R, Sabin CA, Friis-Moller N, Reiss P, EI-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166:1632-1641.
3. Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006; 42:177-182.
4. Arey B, Markov M, Ravi J, Prevette E, Batts K, Nadir A. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007; 21:1066-1068.
5. Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J. Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'. AIDS 2007; 21:1494-1495.
6. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21:187-192.
7. Podevin P, Spiridon G, Terris B, Chauvelot-Moachon L, Guillevin L, Chaussade S, et al. Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient. AIDS 2006; 20:313-315.
8. Sandrine PF, Sylvie A, Andre E, Abdoulaye D, Bernard L, Andre C. Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect? AIDS 2007; 21:1498-1499.
9. Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin Carbonero L, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther 2008; 13:103-107.
10. Mallet VO, Bralet MP, Pol S. Response to Schiano et al., Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Castroenterol 2008; 103:808-809.
11. Morboeuf O, Borgel D, Aiach M, Kaabache T, Gandrille S, Gaussem P. Expression and characterization of recombinant protein S with the Ser 460 Pro mutation. Thromb Res 2000; 100:81-88.
12. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11:787-797.
13. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologie disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with a hypothesis on the pathogenesis. Medicine (Baltimore) 1980; 59:367-379.
14. Wanless IR, Solt LC, Kortan P, Deck JH, Gardiner GW, Prokipchuk EJ. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis. Am J Med 1981; 70:1203-1209.
15. Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, et al. Idiopathic noncirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Cut 2002; 51:275-280.
16. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44:7-14.
17. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255:5521-5524.
18. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59:18-22.
19. Comp PC. Hereditary disorders predisposing to thrombosis. In: Orlando BC. editor. Progress in hemostasis and thrombosis Florida: Grune & Stratton; 1986. pp. 71-102.
20. Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, et al. Protein S deficiency and HIV infection. N Engl J Med 1991; 324:1220.
21. Dillmon MS, Saag MS, Hamza SH, Adler BK, Marques MB. Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature. AIDS Res Hum Retroviruses 2005; 21:753-756.
22. Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 2006; 42:572-577.
23. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993; 81:1801-1807.
24. Redgrave BE, Stone SF, French MA, Krueger R, James IR, Price P. The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med 2005; 6:307-312.
25. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18:1615-1627.
26. Foulon G, Wislez M, Naccache JM, Blanc FX, Rabbat A, IsraelBiet D, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:418-425.
27. Jubault V, Penfornis A, Schillo F, Hoen B, Izembart M, Timsit J, et al. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 2000; 85:4254-4257.
28. Mallet V, Pol S. A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection. Gastroenterol Clin Biol 2007; 31:878-880.